We are live on ! Find out more
IQMD

Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD

Delisted

IQMD was delisted on the 26th of April, 2023.

Back to rankings

Fund managers haven’t disclosed any holdings of IQMD yet.

IQMD Hedge Fund Activity: Q2 2023 in Review

0 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) for Q2 2023, worth a combined $0 — down 100% from $5.26M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of IQMD and 0 opened new positions — a net loss of 8 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Goldman Sachs, exiting entirely with an estimated $2.06M sold.

  • 0 institutional investors held Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) as of Q2 2023, down from 8 in Q1 2023.
  • Funds reported $0 of Intelligent Medicine Acquisition Corp. Class A Common Stock stock for Q2 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Intelligent Medicine Acquisition Corp. Class A Common Stock positions in Q2 2023 and 8 closed out, a net change of -8 holders.
  • The largest Intelligent Medicine Acquisition Corp. Class A Common Stock seller in Q2 2023 was Goldman Sachs, an estimated $2.06M sold.

Based on aggregated 13F filings for Q2 2023.